FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

816021005: Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3849931017 Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3849933019 Insulin lispro protamine- and insulin lispro-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Is a Product containing insulin lispro and insulin lispro protamine (medicinal product) true Inferred relationship Some
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Is a Insulin lispro-containing product in parenteral dose form true Inferred relationship Some
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin lispro true Inferred relationship Some 1
Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin lispro protamine (substance) true Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Is a False Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Is a False Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing only insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Is a True Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start